Atea Pharmaceuticals, Inc. Common Stock (AVIR)
PHARMACEUTICAL PREPARATIONS
Atea Pharmaceuticals, Inc. Common Stock (AVIR) is listed on Nasdaq, where it has traded since October 30, 2020.
- Listed On
- Nasdaq
- Listed Since
- October 30, 2020
- Employees
- 55
- Market Cap
- $415M
About Atea Pharmaceuticals, Inc. Common Stock
Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 121 institutions reported holding AVIR, with 59.4 million shares worth $276.4 million in aggregate. The largest reported holder was FMR, with 12.0 million shares worth $55.8 million. Of the 5 largest holders listed below, 2 added shares, 2 reduced their positions and 1 held its position unchanged during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| FMR | 12,004,064 | $56M | Added 0.45% |
| BlackRock | 8,720,077 | $41M | Added 3.37% |
| Bml Capital Management | 6,952,330 | $32M | Reduced 1.51% |
| Tang Capital Management | 4,814,700 | $22M | Unchanged |
| Vanguard | 4,090,529 | $19M | Reduced 5.18% |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is AVIR?
Atea Pharmaceuticals, Inc. Common Stock (AVIR) is listed on Nasdaq, where it has traded since October 30, 2020.
Who are the largest institutional holders of AVIR?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of AVIR were FMR, BlackRock and Bml Capital Management.
How many institutions own AVIR?
121 institutions reported a position in AVIR for the quarter ended June 30, 2026, worth $276.4 million in total.
Did institutions buy or sell AVIR last quarter?
Of the 5 largest reported holders, 2 added shares, 2 reduced their positions and 1 held its position unchanged during the quarter. Every reported holder and its change is on the SentiSense ownership page for AVIR.
Every reported institutional holder, plus insider and congressional trades in AVIR, on SentiSense.